Diabetic Nephropathy and Pregnancy

Seminars in Nephrology

Volumn 37, Issue 4, 2017, Pages 362-369

  Bramham, Kate ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Diabetes; nephropathy; preeclampsia; pregnancy

Indexed keywords

CAPTOPRIL; ENALAPRIL; HEMOGLOBIN A1C; LABETALOL; METFORMIN; METHYLDOPA; NIFEDIPINE; QUINAPRIL; SULFONYLUREA DERIVATIVE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ARTICLE; BLOOD PRESSURE REGULATION; DIABETIC NEPHROPATHY; DISEASE CONTROL; EVIDENCE BASED MEDICINE; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; KIDNEY FAILURE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PRENATAL CARE; PRIORITY JOURNAL; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK ASSESSMENT; RISK FACTOR; BLOOD; COMPLICATION; DISEASE EXACERBATION; FEMALE; GLUCOSE BLOOD LEVEL; MACROSOMIA; METABOLISM; PATHOPHYSIOLOGY; PREGNANCY DIABETES MELLITUS; PREPREGNANCY CARE; STILLBIRTH;

BLOOD GLUCOSE; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FEMALE; FETAL MACROSOMIA; GLYCATED HEMOGLOBIN A; HUMANS; HYPERTENSION; PRE-ECLAMPSIA; PRECONCEPTION CARE; PREGNANCY; PREGNANCY IN DIABETICS; PRENATAL CARE; PROTEINURIA; STILLBIRTH;

EID: 85030474949     PISSN: 02709295     EISSN: 15584488     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2017.05.008     Document Type: Article

References (53)

1. White, P., Pregnancy complicating diabetes. JAMA 128 (1945), 181–182.
2. Confidential Enquiry into Maternal and Child Health. Diabetes in pregnancy: are we providing the best care? Findings of a national enquiry. 2007, Confidential Enquiry into Maternal and Child Health, England: Wales and Northern Ireland. London.
3. Arrais, R.F., Dib, S.A., The hypothalamus-pituitary-ovary axis and type 1 diabetes mellitus: a mini review. Hum Reprod, 21, 2006 327-327.
4. Holman, N., Lewis-Barned, N., Bell, R., Stephens, H., Modder, J., Gardosi, J., et al. Development and evaluation of a standardized registry for diabetes in pregnancy using data from the Northern, North West and East Anglia regional audits. Diabet Med 28 (2011), 797–804.
5. Klemetti, M.M., Laivuori, H., Tikkanen, M., Nuutila, M., Hiilesmaa, V., Teramo, K., Obstetric and perinatal outcome in type 1 diabetes patients with diabetic nephropathy during 1988-2011. Diabetologia 58 (2015), 678–686.
6. National Institute of Clinical and Health Excellence. Diabetes in pregnancy. Management of diabetes and its complications from preconception to the postnatal period. NICE guideline 3, 2015 [cited 2016 October 3]. Available from https://www.nice.org.uk/guidance/ng3.
7. American Diabetes Association. Executive summary: standards of medical care in diabetes-2011. Diabetes Care 34:Suppl 1 (2011), S4–S10.
8. Bell, R., Glinianaia, S.V., Tennant, P.W., Bilous, R.W., Rankin, J., Peri-conception hyperglycaemia and nephropathy are associated with risk of congenital anomaly in women with pre-existing diabetes: a population-based cohort study. Diabetologia, 2012 Published online 9 February 2012, 10.1007%2Fs00125-012-2455-y.
9. Balsells, M., Garcia-Patterson, A., Gich, I., Corcoy, R., Maternal and fetal outcome in women with type 2 versus type 1 diabetes mellitus: a systematic review and metaanalysis. J Clin Endocrinol Metab 94 (2009), 4284–4291.
10. Tennant, P.W., Glinianaia, S.V., Bilous, R.W., Rankin, J., Bell, R., Pre-existing diabetes, maternal glycated haemoglobin, and the risks of fetal and infant death: a population-based study. Diabetologia 57 (2014), 285–294.
11. Li, D.K., Yang, C., Andrade, S., Tavares, V., Ferber, J.R., Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study. BMJ, 343, 2011, d5931.
12. Bullo, M., Tschumi, S., Bucher, B.S., Bianchetti, M.G., Simonetti, G.D., Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: a systematic review. Hypertension 60 (2012), 444–450.
13. Hod, M., van Dijk, D.J., Karp, M., Weintraub, N., Rabinerson, D., Bar, J., et al. Diabetic nephropathy and pregnancy: the effect of ACE inhibitors prior to pregnancy on fetomaternal outcome. Nephrol Dial Transplant 10 (1995), 2328–2333.
14. Nielsen, L.R., Damm, P., Mathiesen, E.R., Improved pregnancy outcome in type 1 diabetic women with microalbuminuria or diabetic nephropathy: effect of intensified antihypertensive therapy?. Diabetes Care 32 (2009), 38–44.
15. Bar, J., Chen, R., Schoenfeld, A., Orvieto, R., Yahav, J., Ben-Rafael, Z., et al. Pregnancy outcome in patients with insulin dependent diabetes mellitus and diabetic nephropathy treated with ACE inhibitors before pregnancy. J Pediatr Endocrinol Metab 12 (1999), 659–665.
16. Steel, J.M., Johnstone, F.D., Hume, R., Mao, J.H., Insulin requirements during pregnancy in women with type I diabetes. Obstet Gynecol 83 (1994), 253–258.
17. Garcia-Patterson, A., Gich, I., Amini, S.B., Catalano, P.M., de Leiva, A., Corcoy, R., Insulin requirements throughout pregnancy in women with type 1 diabetes mellitus: three changes of direction. Diabetologia 53 (2010), 446–451.
18. Pantalone, K.M., Faiman, C., Olansky, L., Insulin glargine use during pregnancy. Endocr Pract 17 (2011), 448–455.
19. Price, N., Bartlett, C., Gillmer, M., Use of insulin glargine during pregnancy: a case-control pilot study. BJOG 114 (2007), 453–457.
20. Nachum, Z., Ben-Shlomo, I., Weiner, E., Shalev, E., Twice daily versus four times daily insulin dose regimens for diabetes in pregnancy: randomised controlled trial. BMJ 319 (1999), 1223–1227.
21. Ekpebegh, C.O., Coetzee, E.J., van der Merwe, L., Levitt, N.S., A 10-year retrospective analysis of pregnancy outcome in pregestational type 2 diabetes: comparison of insulin and oral glucose-lowering agents. Diabet Med 24 (2007), 253–258.
22. Maresh, M.J., Holmes, V.A., Patterson, C.C., Young, I.S., Pearson, D.W., Walker, J.D., et al., Diabetes, Pre-eclampsia Intervention Trial Study G. Glycemic targets in the second and third trimester of pregnancy for women with type 1 diabetes. Diabetes Care 38 (2015), 34–42.
23. Kimmerle, R., Heinemann, L., Delecki, A., Berger, M., Severe hypoglycemia incidence and predisposing factors in 85 pregnancies of type I diabetic women. Diabetes Care 15 (1992), 1034–1037.
24. Centre for Maternal and Child Enquiries. Saving mothers’ lives: reviewing maternal deaths to make motherhood safer: 2006–08. The eighth report on confidential enquiries into maternal deaths in the United Kingdom. BJOG 118 (2011), 1–203.
25. Carroll, M.A., Yeomans, E.R., Diabetic ketoacidosis in pregnancy. Crit Care Med 33:Suppl 10 (2005), S347–S353.
26. Reece, E.A., Leguizamon, G., Homko, C., Pregnancy performance and outcomes associated with diabetic nephropathy. Am J Perinatol 15 (1998), 413–421.
27. Carr, D.B., Koontz, G.L., Gardella, C., Holing, E.V., Brateng, D.A., Brown, Z.A., et al. Diabetic nephropathy in pregnancy: suboptimal hypertensive control associated with preterm delivery. Am J Hypertens 19 (2006), 513–519.
28. Briggs, G.G., Freeman, R.K., Yaffe, S.K., Drugs in pregnancy and lactation. A reference guide to fetal and neonatal risk, 2011, Lippincott, Williams and Wilkins, Philadelphia.
29. Reece, E.A., Coustan, D.R., Hayslett, J.P., Holford, T., Coulehan, J., O'Connor, T.Z., et al. Diabetic nephropathy: pregnancy performance and fetomaternal outcome. Am J Obstet Gynecol 159 (1988), 56–66.
30. Biesenbach, G., Grafinger, P., Zazgornik, J., Helmut, Stöger, Perinatal complications and three-year follow up of infants of diabetic mothers with diabetic nephropathy stage IV. Ren Fail 22 (2000), 573–580.
31. Star, J., Carpenter, M.W., The effect of pregnancy on the natural history of diabetic retinopathy and nephropathy. Clin Perinatol 25 (1998), 887–916.
32. Biesenbach, G., Grafinger, P., Stoger, H., Zazgornik, J., How pregnancy influences renal function in nephropathic type 1 diabetic women depends on their pre-conceptional creatinine clearance. J Nephrol 12 (1999), 41–46.
33. Gordon, M., Landon, M.B., Samuels, P., Hissrich, S., Gabbe, S.G., Perinatal outcome and long-term follow-up associated with modern management of diabetic nephropathy. Obstet Gynecol 87 (1996), 401–409.
34. Ekbom, P., Damm, P., Feldt-Rasmussen, B., Feldt-Rasmussen, U., Molvig, J., Mathiesen, E.R., Pregnancy outcome in type 1 diabetic women with microalbuminuria. Diabetes Care 24 (2001), 1739–1744.
35. Bell, R., Bailey, K., Cresswell, T., Hawthorne, G., Critchley, J., Lewis-Barned, N., Trends in prevalence and outcomes of pregnancy in women with pre-existing type I and type II diabetes. BJOG 115 (2008), 445–452.
36. Hiilesmaa, V., Suhonen, L., Teramo, K., Glycaemic control is associated with pre-eclampsia but not with pregnancy-induced hypertension in women with type I diabetes mellitus. Diabetologia 43 (2000), 1534–1539.
37. Jensen, D.M., Damm, P., Ovesen, P., Molsted-Pedersen, L., Beck-Nielsen, H., Westergaard, J.G., et al. Microalbuminuria, preeclampsia, and preterm delivery in pregnant women with type 1 diabetes: results from a nationwide Danish study. Diabetes Care 33 (2010), 90–94.
38. Garner, P.R., D'Alton, M.E., Dudley, D.K., Huard, P., Hardie, M., Preeclampsia in diabetic pregnancies. Am J Obstet Gynecol 163 (1990), 505–508.
39. Clausen, P., Ekbom, P., Damm, P., Feldt-Rasmussen, U., Nielsen, B., Mathiesen, E.R., et al. Signs of maternal vascular dysfunction precede preeclampsia in women with type 1 diabetes. J Diabetes Complications 21 (2007), 288–293.
40. Khoury, J.C., Miodovnik, M., LeMasters, G., Sibai, B., Pregnancy outcome and progression of diabetic nephropathy. What's next?. J Matern Fetal Neonatal Med 11 (2002), 238–244.
41. Yu, Y., Jenkins, A.J., Nankervis, A.J., Hanssen, K.F., Scholz, H., Henriksen, T., et al. Anti-angiogenic factors and pre-eclampsia in type 1 diabetic women. Diabetologia 52 (2009), 160–168.
42. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329 (1993), 977–986.
43. Verier-Mine, O., Chaturvedi, N., Webb, D., Fuller, J.H., Is pregnancy a risk factor for microvascular complications? The EURODIAB Prospective Complications Study. Diabet Med 22 (2005), 1503–1509.
44. Miodovnik, M., Rosenn, B.M., Khoury, J.C., Grigsby, J.L., Siddiqi, T.A., Does pregnancy increase the risk for development and progression of diabetic nephropathy [discussion]?. Am J Obstet Gynecol 174 (1996), 1189–1191.
45. Imbasciati, E., Gregorini, G., Cabiddu, G., Gammaro, L., Ambroso, G., Del Giudice, A., et al. Pregnancy in CKD stages 3 to 5: fetal and maternal outcomes. Am J Kidney Dis 49 (2007), 753–762.
46. Loukovaara, S., Immonen, I., Teramo, K.A., Kaaja, R., Progression of retinopathy during pregnancy in type 1 diabetic women treated with insulin lispro. Diabetes Care 26 (2003), 1193–1198.
47. Klein, B.E., Moss, S.E., Klein, R., Effect of pregnancy on progression of diabetic retinopathy. Diabetes Care 13 (1990), 34–40.
48. Bagg, W., Neale, L., Henley, P., MacPherson, P., Cundy, T., Long-term maternal outcome after pregnancy in women with diabetic nephropathy. N Z Med J, 116, 2003, U566.
49. Rossing, K., Jacobsen, P., Hommel, E., Mathiesen, E., Svenningsen, A., Rossing, P., et al. Pregnancy and progression of diabetic nephropathy. Diabetologia 45 (2002), 36–41.
50. Damm, J.A., Asbjornsdottir, B., Callesen, N.F., Mathiesen, J.M., Ringholm, L., Pedersen, B.W., et al. Diabetic nephropathy and microalbuminuria in pregnant women with type 1 and type 2 diabetes: prevalence, antihypertensive strategy, and pregnancy outcome. Diabetes Care 36 (2013), 3489–3494.
51. Miodovnik, M., Skillman, C., Holroyde, J.C., Butler, J.B., Wendel, J.S., Siddiqi, T.A., Elevated maternal glycohemoglobin in early pregnancy and spontaneous abortion among insulin-dependent diabetic women. Am J Obstet Gynecol 153 (1985), 439–442.
52. Piccoli, G.B., Cabiddu, G., Attini, R., Vigotti, F.N., Maxia, S., Lepori, N., et al. Risk of adverse pregnancy outcomes in women with CKD. J Am Soc Nephrol 26 (2015), 2011–2022.
53. Piccoli, G.B., Clari, R., Ghiotto, S., Castelluccia, N., Colombi, N., Mauro, G., et al. Type 1 diabetes, diabetic nephropathy, and pregnancy: a systematic review and meta-study. Rev Diabet Stud 10 (2013), 6–26.